Checklist to gauge real-world studies

Share this article:

Researchers have developed and tested a checklist that aims to evaluate comparative effectiveness research and distinguish real-world studies that are good enough for decision-making about treatments.

An agreed-upon set of assessment elements is important, say co-developers Quintiles and the National Pharmaceutical Council. Called the Good ReseArch for Comparative Effectiveness (GRACE) checklist, it features 11 items about research and data methods, based on existing literature and guidance from experts, and was published in the March issue of Journal of Managed Care Pharmacy.

GRACE stands out, said Quintiles Global Chief of Scientific Affairs and SVP Nancy Dreyer, lead author of the study, because it's been tested by “collaborators from public and private sectors in North and South America, Europe, Asia and Africa.”

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?